Historical Valuation
Daxor Corp (DXR) is now in the Overvalued zone, suggesting that its current forward PS ratio of 708.68 is considered Overvalued compared with the five-year average of 15.10. The fair price of Daxor Corp (DXR) is between 1.26 to 8.05 according to relative valuation methord. Compared to the current price of 13.80 USD , Daxor Corp is Overvalued By 71.33%.
Relative Value
Fair Zone
1.26-8.05
Current Price：13.80
71.33%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Daxor Corp (DXR) has a current Price-to-Book (P/B) ratio of 2.01. Compared to its 3-year average P/B ratio of 1.38 , the current P/B ratio is approximately 45.35% higher. Relative to its 5-year average P/B ratio of 1.83, the current P/B ratio is about 9.91% higher. Daxor Corp (DXR) has a Forward Free Cash Flow (FCF) yield of approximately 1.94%. Compared to its 3-year average FCF yield of -3.37%, the current FCF yield is approximately -157.56% lower. Relative to its 5-year average FCF yield of -4.00% , the current FCF yield is about -148.46% lower.
P/B
Median3y
1.38
Median5y
1.83
FCF Yield
Median3y
-3.37
Median5y
-4.00
Competitors Valuation Multiple
AI Analysis for DXR
The average P/S ratio for DXR competitors is 141.74, providing a benchmark for relative valuation. Daxor Corp Corp (DXR.O) exhibits a P/S ratio of 708.68, which is 400% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for DXR
1Y
3Y
5Y
Market capitalization of DXR increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of DXR in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is DXR currently overvalued or undervalued?
Daxor Corp (DXR) is now in the Overvalued zone, suggesting that its current forward PS ratio of 708.68 is considered Overvalued compared with the five-year average of 15.10. The fair price of Daxor Corp (DXR) is between 1.26 to 8.05 according to relative valuation methord. Compared to the current price of 13.80 USD , Daxor Corp is Overvalued By 71.33% .
What is Daxor Corp (DXR) fair value?
DXR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Daxor Corp (DXR) is between 1.26 to 8.05 according to relative valuation methord.
How does DXR's valuation metrics compare to the industry average?
The average P/S ratio for DXR's competitors is 141.74, providing a benchmark for relative valuation. Daxor Corp Corp (DXR) exhibits a P/S ratio of 708.68, which is 400.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Daxor Corp (DXR) as of Jan 09 2026?
As of Jan 09 2026, Daxor Corp (DXR) has a P/B ratio of 2.01. This indicates that the market values DXR at 2.01 times its book value.
What is the current FCF Yield for Daxor Corp (DXR) as of Jan 09 2026?
As of Jan 09 2026, Daxor Corp (DXR) has a FCF Yield of 1.94%. This means that for every dollar of Daxor Corp’s market capitalization, the company generates 1.94 cents in free cash flow.
What is the current Forward P/E ratio for Daxor Corp (DXR) as of Jan 09 2026?
As of Jan 09 2026, Daxor Corp (DXR) has a Forward P/E ratio of 2.87. This means the market is willing to pay $2.87 for every dollar of Daxor Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Daxor Corp (DXR) as of Jan 09 2026?
As of Jan 09 2026, Daxor Corp (DXR) has a Forward P/S ratio of 708.68. This means the market is valuing DXR at $708.68 for every dollar of expected revenue over the next 12 months.